Combinatorial interactions between cis-elements and trans-acting factors are required for the regulation of cardiac gene expression during normal cardiac development and pathologic cardiac hypertrophy. Sp factors bind GC-boxes and are implicated in the recruitment and assembly of the basal transcriptional complex. In this study we show that the cardiac troponin T promoter contains a GC box that is necessary for basal and cAMP-mediated activity of cTnT promoter constructs transfected in embryonic cardiomyocytes. Cardiac nuclear proteins bind the cTnT GC-box in a sequence-specific fashion and are comprised of Sp1, 2 and 3 protein factors. By chromatin immunoprecipitation, Sp1 binds the cTnT promoter "in vivo". Cotransfected Sp1 transactivates the cTnT promoter in cardiac myocytes in culture. 
INTRODUCTION
The Sp family of transcription factors is characterized by a series of 3 zinc fingers at the carboxy-terminal end of the protein which are preceded by glutamine-rich and serine-threonine rich domains (8, 28) . Sp-proteins bind GC-boxes and the related GT/CACC-box motifs, and are implicated in the recruitment and assembly of the basal transcriptional complex. GC boxes have been implicated in the regulation of cardiac promoters, but the direct effects of Sp family members on cardiac promoter activity have not been defined.
We use the cardiac troponin T gene promoter as a model of cardiac-specific gene expression during myocardial differentiation (3, 5, 22, 27, 29) . The cTnT promoter is developmentally regulated by numerous promoter motifs and trans-acting factors including MCAT or TEF-1 binding sites, AT rich/MEF-2 binding sites, GATA motifs and Nkx 2.5. The significance of the GC-box for cTnT promoter function is not known, nor is the role of the Sp family of transcription factors in the regulation of cTnT promoter activity. In this study we use transient cotransfections of Sp expression constructs with cTnT promoter constructs in embryonic cardiomyocytes in order to define the transactivating function of Sp1/Sp3. We show that Sp1 activates while Sp3 represses transiently transfected cTnT promoter constructs in cardiomyocyte cultures. Although the evaluation of cis elements in the regulation of promoter function has been well established in the avian embryonic cardiomyocyte system, we found it necessary to determine in vivo correlates between Sp1/Sp3 and sarcomeric protein expression. In order to determine the in vivo relevance of Sp factors to myocardial gene expression, we report their chromatin binding and the changing expression patterns of sarcomeric proteins and Sp factors in a clinically-relevant and novel model of pathologic cardiac hypertrophy.
Chemiluminescence was then used for visualization of bands. Parallel SDS gels and immunoblots of beta-actin and GAPDH controls were performed to verify sample integrity and quantity.
To identify proteins in gel shift complexes (14) the mobility shift reactions were scaled up 5- fold in a final volume of 20 ul. Following electrophoresis, the gels were soaked in 2% SDS, 62.5 mM Tris, 25 mM dithiothreitol and then dried. The DNA-protein complexes were then identified by autoradiography and the band of interest was excised and loaded on a 10% SDS-PAGE gel. The immunoblot was then carried out as above. Tissue culture, cell transfections and reporter gene assays: Hearts were harvested from embryonic day 6-12 chicks and cardiomyocyte cultures established using standard techniques (5, 13-15, 18-22, 26) . The differentiation state of cardiomyocytes was determined by light microscopy, presence of beating cardiomyocytes, immunohistochemistry for MF20 and western blotting for myosins, cTnT, GATA-4, MEF-2, and NKx2.5. Plasmid constructs were transfected according to the manufacturer's protocol (Qiagen, Effectene Transfection kit) with minor modifications. Briefly, cultured cells were washed and resuspended in serum-free medium. -268cTnTpGL2 promoter constructs (300ng) with wild-type and mutated GC box were transfected.Sp1, Sp2, and Sp3 expression constructs (see above) were cotransfected at concentrations ranging from 2 ng to 2000 ng in a total volume of 200ul. Cyclic AMP-mediated activation of -268 cTnT promoter constructs was determined by adding forskolin at a concentration of 20µM for 60 minutes to cardiomyocytes in culture. Reporter gene activity was determined using the Luciferase reporter assay (Promega, Madison WI). Firefly light intensity was read on a Luminometer TD-20/20, DLR Ready (Turner Designs Instrument, Sunnyvale, CA). Cotransfection with TK-reporter was used to standardize for transfection variability. Cotransfection efficiency of Sp expression constructs was verified using pSV-B-gal (Promega, Madison WI) and/or pAAV-GFP staining. Reporter gene activity is expressed as mean + standard deviation. Statistical comparisons were performed using paired t-tests with level of significance set at 0.01.
Co-Immunoprecipitation
Chromatin Immunoprecipitation. (ChIP) All ChIP assays were performed based on the protocols of the chromatin immunoprecipitation assay kit (Upstate, Lake Placid NY)(4). 5 micrograms of primary antibody against Sp1, DTEF-1, GATA-4 and PARP was added to a 500 ul chromatin sample for the IP reaction . ChIP dilution buffer and pre-immune rabbit serum were used as controls for nonspecific interactions and DNA contamination. Anti beta-actin and anti cTnT antibodies were used as negative controls.
PCR . Following DNA purification, samples were subjected to PCR with primers designed for the chick heart cTnT promoter (cTnT-268) as follows:
Upper primer: 5'GCTGGCTGGCTTGTGTCA-3'
Lower primer: 5'-CTTGGGGGGCAGAGGCTTT-3'
The primers used for PCR were designed by a primer analysis software (Oligo 6.8, Molecular
Biology Insights, Inc. Cascade, CO). The amplified PCR product is 265 bp Immunohistochemistry. Embryonic chick cardiac myocytes were prepared as described (15) . To perform immunofluorescent staining, the cells were plated in collagen-coated (Collagen, Rat tail. Roche Diagnostics Corporation, Indianapolis, IN-50 mg/ml in 0.2% acetic acid) 2-well chamber slides (4.2 cm2/well, Nalgene Nunc International Corp, Naperville, IL) with a seeding density of 0.1 x 10 6 , and then cultured in a 5% CO 2 incubator at 37 °C for 72-96 hours.
Following fixation in 0.2% PFA for 10 min at room temperature cells were washed in PBS and then blocked in goat serum (vector laboratories, Burlingame CA) for 20 minutes at 37 °C. Comparisons between shunt and age-matched controls were made by using an unpaired t-test. P < 0.05 was considered significant.
RESULTS
The proximal GC-box is required for cTnT promoter activity in cultured embryonic chick cardiomyocytes. Maximal expression of reporter gene driven by cardiac troponin T promoter constructs in vitro requires cis-elements within the 268 nucleotide region upstream of the transcription initiation site ( Figure 1A ). Within the -268cTnT promoter, tandem MCAT sites and an AT-rich/MEF-2 binding site have been shown to be essential for promoter activity. We sought to determine the contribution of the proximal GC-box (nucleotides -49 to -57), a putative Sp binding site, to promoter activity. Site-directed mutagenesis was used to generate promoter constructs with a mutated GC-box. Transient transfections of embryonic cardiomyocyte cultures with mutated promoter constructs resulted in a 11-fold reduction in promoter activity relative to wildtype, that was statistically significant (-268 cTnT = 100%, vs. -268 cTnT GC-box mut = 9%, n=12, p<0.0001).
Forskolin has a unique ability to stimulate adenylate cyclase activity and increase intracellular cyclic adenosine monophosphate (cAMP) thus activating cAMP-dependent protein kinase and other cAMP receptor proteins. Addition of forskolin results in a 4-5 fold increase in reporter gene activity. Cyclic AMP mediated activation of the cTnT promoter requires an intact GC box, because forskolin addition to GC-box mutated promoters did not increase promoter activity (Fig 1B) .
The cTnT GC-box binds sequence-specific cardiac nuclear activities, which include Sp1, 2 and 3 protein factors. Gel retardation and supershift assays were performed using embryonic chick cardiac nuclear extracts, GC-box DNA probes (26-mer) and antibodies specific to Sp1, 2, 3, and 4.
The cTnT GC-box binds cardiac nuclear protein activities generating two mobility shift complexes, The in vitro binding of the cTnT GC-box was further evaluated using Sp1 and Sp3 polypeptides expressed in eukaryotic cells. Schneider cells were transfected with Sp1 and Sp3 expression constructs, cultured and nuclear protein was extracted and used for mobility shift assays. To further analyze the Sp family members in cardiac tissue, mobility shift complexes C-1 and C-2 were excised, and proteins were eluted and probed in Western blots using antibodies specific for Sp1, Sp2 and Sp3 ( Figure 4 ). The mobility shift complexes generated from cTnT GC- Expression patterns of Sp factors in embryonic chick nuclear extracts. The protein expression profiles of Sp family members in avian embryonic tissues were determined using antibodies specific for Sp1, 2, 3, 4 ( Figure 5 ). Sp1 is expressed as either a 95 kDa or 106 kDa isoprotein, and each are widely distributed in various embryonic tissues, including heart, skeletal muscle, skin, lung, liver, gizzard, kidney and brain. In heart and skeletal muscle, the 95 kDa isoform is expressed at higher levels than the 106 kDa protein. In gizzard, the 106 kDa isoform is highly expressed and the 95 kDa isoform is not detected. The expression of Sp2 is tissue-restricted. Sp2 is expressed as an 80 kDa protein in heart, fibroblasts and gizzard, but is not detected in other avian embryonic nuclear extracts.
Like Sp1, Sp3 expression is more widely distributed. Two isoforms are detected. A 60 kDa protein is expressed at higher levels than the 100 kDa isoform. Similar to Sp1, Sp3 expression is lower in gizzard. The 100 kDa isoform is undetectable in gizzard, while trace levels of the 60 kDa protein are seen in that tissue. In heart, both isoforms are expressed. The expression of Sp4 is restricted to brain tissue, where a single 120 kDa protein is detected. DNA from the immunoprecipitated sample was then purified and subject to PCR using primers specific to the cTnT promoter (265 base pairs). Antibody to Sp1, DTEF-1, PARP and GATA factors immunoprecipitates chromatin from cardiac nuclear extracts that produces a PCR fragment spanning the 265 base pair region upstream of the transcription initiation site, implicating these factors bind the cTnT promoter in vivo.
Sp3 represses Sp1-mediated transcriptional activation of the cTnT gene in embryonic
cardiomyocytes. In order to determine the transcriptional effects of Sp factors on cTnT promoter activity, co-transfection of Sp expression constructs and cTnT promoter constructs in embryonic chick cardiomyocytes were performed ( Figure 7 ). Co-transfection of Sp1 (5 ng, n=22) resulted in a moderate, statistically significant superactivation of promoter activity above baseline (268 cTnT=100%, 268 cTnT + Sp1=171%, n=22, p 0.0001). Sp3, however, had an inhibitory effect on promoter activity, while Sp2 also produced a moderate increase in promoter activity (268 cTnT=100%, 268 cTnT + Sp3=32%, n=10, p<0.001; 268 cTnT + Sp2=149%, n=18, p=0.01). The is expressed in cardiac myocytes ( Figure 8A , B, C). Sp1 also co-localized in cells that stained positively for vimentin, caldesmon and cytokeratin implicating Sp1 expression in the fibroblasts, smooth muscle and epithelial cells of the heart, respectively (data not shown). Sp3 immunostaining however did not co-localize with MF-20 positive cells suggesting that Sp3 is present at undetectable levels or that it is not specifically expressed in the cardiomyocyte population within the avian embryonic heart on embryonic day 6-12 ( Figure 9A , B, C). Embryonic chick cardiac cultures immunolabeled with Sp3 showed co-localization with anti-vimentin, caldesmon and cytokeratin antibody labels suggesting that Sp3 expression in the heart occurs within fibroblasts, smooth muscle cells and epicardial-epithelial cells, respectively (data not shown).
Having Western blot analysis of chamber specific tissue was performed for both shunted (n=5) and control hearts (n=5) and band density scanned to assess relative protein levels of myosins, cTnT and Sp factors. Figure 11 shows a representative western blot of sarcomeric and Sp protein levels in the atria and ventricles of shunted and control lambs. There was no significant difference in GAPDH or bactin expression levels between control and shunted animals. Shunted hearts had significant increases in myosin expression within both atria and ventricles. Cardiac troponin T protein levels were also significantly increased in the both atria and ventricles. In addition to increased cTnT protein levels, there was an upregulation of the embryonic/fetal high molecular weight isoform in the shunted, hypertrophied hearts.
Sp1 and Sp3 levels are modulated during ventricular hypertrophy in shunted lambs-
Densitometric analysis of Sp1 protein levels were significantly increased in all chambers (except the septum) following shunting, volume loading of the heart and development of pathologic cardiac hypertrophy. Concomitant with an increase in Sp1 protein levels, there was a decrease in Sp3 expression levels in all 4 cardiac chambers.
DISCUSSION
The cardiac troponin T promoter contains a GC box that is necessary for basal and cAMP mediated activity of cTnT promoter constructs transfected in avian embryonic cardiomyocytes. The Sp1 activates the -268 cTnT promoter. The necessity of the GC box for cTnT promoter activity is consistent with other reports in the literature which suggest that cardiac promoters require Sp1 binding elements for activity. Both the human and murine cardiac troponin I promoters require their respective GC-elements for promoter activity (9, 12) . Mutation of murine GC/GA elements within the cTnI promoter produces a 4-5 fold reduction of promoter activity comparable to that seen for the avian cTnT promoter. Putative Sp1 promoter elements have also been shown to be required for optimal activity of cardiac and skeletal alpha actin, SERCA-ATPase and Na/K-ATPase beta 1 subunit genes in cultured cells (6, 16, 24, 31, 33) . These studies do not show direct transactivation of promoter constructs cotransfected with expressed Sp factors. In the current study we show that the GC-box within the cTnT promoter is necessary for basal and cAMP mediated promoter activity and +  +  --------Expressed Sp1  ---+  +  +  +  +  ---Expressed Sp3  --------+  +  +  50x GCbox wt  ----+  ------100xGC box wt  --+  --+  ---+  -50x GCboxmut  ------+  ----100x Values are means ± SD; n = 5 shunt lambs and 5 twin or age-matched controls. * P < 0.05 vs. control lambs.
